Skip to Content

GSI 9883 (Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg)

Generic Name: bictegravir/emtricitabine/tenofovir alafenamide

Pill with imprint GSI 9883 is Brown, Capsule-shape and has been identified as Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg. It is supplied by Gilead Sciences, Inc..

Biktarvy is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 9883

Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883
Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883
Biktarvy bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg GSI 9883

Biktarvy

Generic Name
bictegravir/emtricitabine/tenofovir alafenamide
Imprint
GSI 9883
Strength
bictegravir 50 mg / emtricitabine 200 mg / tenofovir alafenamide 25 mg
Color
Brown
Size
15.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-2501
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, magnesium stearate, water, titanium dioxide, magnesium silicate, ferrosoferric oxide, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.